Hikal inks a multi-year global CDMO contract with Europe-based agrochem company

SENSEX 75,306.93

+ 847.40

NIFTY 23,291.10

+ 238.00

CRUDEOIL 9,488.00

 -449.00

GOLD 138,654.00

+ 169.00

SILVER 182,415.00

+ 3,283.00

SENSEX 75,306.93

+ 847.40

NIFTY 23,291.10

+ 238.00

NIFTY 23,291.10

+ 238.00

CRUDEOIL 9,488.00

 -449.00

CRUDEOIL 9,488.00

 -449.00

GOLD 138,654.00

+ 169.00

'; } document.getElementById("lgdv").innerHTML = htmlElements; } function numberformat(i) { return Number(parseFloat(i).toFixed(2)).toLocaleString('en', { minimumFractionDigits: 2 }) } async function gatherResponse(response) { const { headers } = response; const contentType = headers.get('content-type') || ''; if (contentType.includes('application/json')) { return await response.json() } return response.text(); } function getWidth() { if (Math.max(document.body.scrollWidth,document.documentElement.scrollWidth,document.body.offsetWidth,document.documentElement.offsetWidth,document.documentElement.clientWidth) > 991) { document.getElementById("mob").style.display = "none"; document.getElementById("lgdv").style.display = "block"; } else { document.getElementById("mob").style.display = "block"; document.getElementById("lgdv").style.display = "none"; } } getWidth(); THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.

Commercial launch of the product is expected by end FY 2026–27, the company said, adding that volumes are anticipated to grow as the regulatory approvals come in from global markets

By BL Mumbai Bureau

Updated - November 02, 2026 at 02:55 PM.

Hikal Limited has signed a multi-year contract with a Europe-based global agrochemical company to supply a specialised agrochemical product to markets worldwide, it said.

The contract executed through Hikal’s Crop Protection division involves contract development and manufacturing (CDMO) of the product “for which Hikal undertook process development and scale-up,” it added.

Commercial launch of the product is expected by end FY 2026–27, the company said, adding that volumes are anticipated to grow as the regulatory approvals come in from global markets.

Hikal partners with global companies across pharmaceuticals, crop protection, animal health and specialty chemicals, and the latest partnership strengthens Hikal’s Crop Protection business, expanding its portfolio of specialised offerings for global customers, the company said.

Sameer Hiremath, Hikal Chairman & Managing Director, said: “This contract marks an important milestone for our crop protection business, converting nearly three years of collaborative development and scale-up into a long-term commercial partnership.”

API plant

Just days ago, Hikal had said, its active pharmaceutical ingredient (API) facility in Bengaluru had received a GMP (Good Manufacturing Practices) certificate from Swissmedic, the Swiss Agency for Therapeutic Products.

The certificate confirms that the facility meets the GMP requirements of the Mutual Recognition Agreement between the European Union and Switzerland, it added.

Published on November 2, 2026

THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.Sign into Unlock benefits!

• Access 10 free stories per month
• Get notified by email for early preview to new features, discounts & offers